# The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.

> **NCT03927677** · PHASE1 · COMPLETED · sponsor: **LG Chem** · enrollment: 24 (actual)

## Conditions studied

- Gout
- Hyperuricemia

## Interventions

- **DRUG:** Xanthine Oxidase Inhibitor

## Key facts

- **NCT ID:** NCT03927677
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-05
- **Primary completion:** 2019-11-26
- **Final completion:** 2019-11-26
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03927677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03927677, "The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03927677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*